We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Established in 2017 and headquartered in Seoul, South Korea, DK Life Science Co., Ltd. operates as a pharmaceutical enterprise focused on the creation and commercialization of diagnostic pharmaceuticals and medical instruments. The company extends its reach to markets across South Korea, the European Union, Japan, and other global territories. Its product portfolio encompasses a variety of items, including active pharmaceutical ingredients (APIs), injectable medications, personal blood glucose monitoring systems, mobile computed tomography (CT) devices, and ultrasonic equipment.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save 303810.KQ and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
